Amneal Pharmaceuticals (AMRX) EBIT (2017 - 2026)
Amneal Pharmaceuticals' EBIT came in at $129.77 million for Q2 2026, up 16.5% from $111.37 million a year earlier but down 8.5% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBIT (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Amneal Pharmaceuticals reported EBIT of $453.92 million, up 20.6% year-over-year; for FY2025, it was $394.1 million, up 58.1% from FY2024.
- EBIT carries a five-year compound annual growth rate of 34.0% (FY2020 to FY2025).
- Going back by year, EBIT was $249.33 million in FY2024 (+22.0%), $204.37 million in FY2023, -$94.93 million in FY2022 and $152.72 million in FY2021 (+67.5%).
- The five-year range for quarterly EBIT is -$198.62 million (Q2 2022) to $141.77 million (Q1 2026).
- Year-over-year, EBIT has increased for three consecutive quarters, with growth averaging 79.0% over the last seven quarters.
- The fastest year-over-year change in EBIT over five years came in Q4 2024 (growth of 434.0%), and the weakest in Q4 2023 (a decline of 60.6%).
- Business Quant data shows AMRX's EBIT at $141.77 million (Q1 2026), $112.03 million (Q4 2025) and $70.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Amneal Pharmaceuticals | 6.55 Bn | 5.82 Bn | 334.51 Mn | 129.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.77 Mn |
| Mar 31, 2026 | 141.77 Mn |
| Dec 31, 2025 | 112.03 Mn |
| Sep 30, 2025 | 70.34 Mn |
| Jun 30, 2025 | 111.37 Mn |
| Mar 31, 2025 | 100.35 Mn |
| Dec 31, 2024 | 75.79 Mn |
| Sep 30, 2024 | 88.81 Mn |
| Jun 30, 2024 | 95.47 Mn |
| Mar 31, 2024 | -10.75 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 75.65 Mn |
| Jun 30, 2023 | 80.08 Mn |
| Mar 31, 2023 | 34.45 Mn |
| Dec 31, 2022 | 36.03 Mn |
| Sep 30, 2022 | 44.35 Mn |
| Jun 30, 2022 | -198.62 Mn |
| Mar 31, 2022 | 23.31 Mn |
| Dec 31, 2021 | 11.18 Mn |
| Sep 30, 2021 | 28.52 Mn |
API Access
Amneal Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();